AYUSO E ET AL: "High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency", GENE THERAPY, vol. 17, no. 4, 3 December 2009 (2009-12-03), pages 503-510, XP055073587, ISSN: 0969-7128, DOI: 10.1038/gt.2009.157 (B1)

HAUCK B ET AL: "A scalable Manufacturing Platform for Purification of AAV Serotypes 2, 5, 6 and 8 for IND-Supporting Pre-Clinical Studies and Clinical Trials", MOLECULAR THERAPY, vol. 17, no. supp 1, 41, May 2009 (2009-05), page S17, XP002712089, (B1)

HAUCK B ET AL: "Process characterisation and GMP Manufacture of a Gene Transfer Vector for Leber Congenital Amaurosis", MOLECULAR THERAPY, vol. 15, no. supp 1, 432, May 2007 (2007-05), page S167, XP002712090, (B1)

MAGUIRE A M ET AL: "Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis", NEW ENGLAND JOURNAL OF MEDICINE, vol. 358, no. 21, 22 May 2008 (2008-05-22) , pages 2240-2248, XP055027817, ISSN: 0028-4793, DOI: 10.1056/NEJMoa0802315 (B1)

MAGUIRE A M ET AL: "Slides to the Discussion of Human Gene Transfer Protocol #0510-740", 102nd meeting of the Recombinant DNA Advisory Committee (RAC), NIH Office of Biotechnology Activities, Bethesda, Maryland, USA, 13 December 2005 (2005-12-13), pages 1-49, XP055073564, Retrieved from the Internet: URL:http://webconferences.com/nihoba/740_M aGuire.pdf [retrieved on 2013-07-30] (B1)

MAGUIRE A M ET AL: "Supplementary Appendix to MAGUIRE A M et al., N ENGL J MED;358;2240-8", New England Journal of Medicine, vol. 358 22 May 2008 (2008-05-22), pages 1-50, XP055073559, DOI: 10.1056/NEJMoa0802315 Retrieved from the Internet: URL:http://www.nejm.org/action/showSupplem ents?doi=10.1056%2FNEJMoa0802315 [retrieved on 2013-07-30] (B1)

WRIGHT J F: "Adeno-associated Virus Vectors to Support Clinical Studies", Presentation at the 11th Annual Meeting of the American Society for Gene Therapy, 28 May 2008, Boston, USA, , 28 May 2008 (2008-05-28), XP002712088, Retrieved from the Internet: URL:www.gtrp.org/docs/CHOP%20AAV%20Lab_5.2 8.08.ppt [retrieved on 2013-07-30] (B1)

US-A1- 2006 035 364 (B1)

US-A1- 2007 243 615 (B1)

WO-A1-2005/118792 (B1)

WO-A1-2008/128251 (B1)

WRIGHT J F ET AL: "Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65", CURRENT GENE THERAPY, vol. 10, no. 5, 1 October 2010 (2010-10-01), pages 341-349, XP055073585, (B1)

OKADA T ET AL: "Scalable Purification of Adeno-associated Virus Serotype 1 (AAV1) and AAV8 Vectors, Using Dual Ion-Exchange Adsorptive Membranes", HUMAN GENE THERAPY, vol. 20, no. 9, 1 September 2009 (2009-09-01), pages 1013-1021, XP055073581, ISSN: 1043-0342, DOI: 10.1089/hum.2009.006 (B1)